Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Innovation & geistiges Eigentum · 24.2.20231 Min. Lesezeit
Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The United States Patent and Trademark Office (USPTO), Department of Commerce, in collaboration with the United States Food and Drug Administration (FDA), Department of Health and Human Services, is extending the written comment period for the notice titled "Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments" that was published in the Federal Register on November 7, 2022, until March 10, 2023.
Originalsprache der Quelle: Federal Register — Patent and Trademark OfficeOriginalquelle öffnen →